跳至主要内容
临床试验/IRCT20230629058615N1
IRCT20230629058615N1已完成Unknown

Bioequivalence study of 100 mg doxycycline delayed-release capsules manufactured by Behshad Daroo company with reference product manufactured by Avet (Heritage)

Behshad Daroo Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
All

入选标准

  • Volunteer’s health (based on the results of physical examinations and clinical tests)
  • Volunteer’s health (based on the results of physical examinations and clinical tests)
  • Body mass index of 18.5-30 kg/m2
  • No history of allergy to tetracycline antibiotics and excipients used in the products formulations
  • No administration of potent cytochrome p450 inhibitors 4 weeks before start of the study
  • No history of diseases affecting the pharmacokinetic processes of the drug
  • No history of smoking, alcohol and narcotics use
  • Not being pregnant or breastfeeding
  • Adherence to study criteria based on ethical commitment and informed consent
  • Absence of severe liver failure (Child Pugh B or C) or kidney failure (GFR<30 mL/min/1.73 m2)

排除标准

  • Tobacco or alcohol use, acute or chronic
  • Failure to obtain any of the mentioned items regarding health tests
  • Drug administration before and during the study
  • Lack of adherence to study criteria
  • Incidence of adverse reactions
  • liver failure (Child Pugh B or C) or kidney failure (GFR<30 mL/min/1.73 m2)

研究者

发起方
Behshad Daroo Company

相似试验